medicaid approved glp 1 US states drop coverage of GLP-1 weight-loss drugs as demand rises | US healthcare Louisiana lawmakers are considering a

doi: 10.1007/s10557-025-07670-9, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar] 28

Whether you are on semaglutide , tirzepatide , or retatrutide , the nutritional gaps are real, and closing them can mean the difference between losing weight while feeling terrible and losing weight while actually thriving

Between these two, metformin is our first-line preference as it helps not only with antipsychotic-related weight gain but also with the metabolic side effects of antipsychotics (insulin resistance, fasting glucose, triglycerides, and hyperprolactinemia), earning it a recommendation from the APA for this purpose

EXCITING NEWS As a coach, I believe learning never stops

venues frequently adjust menus to accommodate vegetarians, vegans or non-drinkers whose needs shape group decisions